Pharma, healthcare firms eye Rs 13,000-cr IPO wave over 9 months
Indian pharmaceutical and healthcare firms are set for a significant fundraising push, aiming to garner ₹12,000-13,000 crore through IPOs in the coming months. Approximately fifteen companies are expected to enter the primary market, with fertility and women's health segments particularly in (...)
Site référencé: The Economic Times
The Economic Times
Silver ETFs offer up to 55% return so far in 2025. Is there more sheen left ?
26/09/2025
Market leadership could emerge from BFSI, metals and auto sector, says Sudip Bandyopadhyay
26/09/2025
Put a seatbelt on your portfolio : How hybrid funds protect growth and limit crashes
26/09/2025
Asian stocks drop after Wall Street rally stalls
26/09/2025
India's REITs surge as SEBI reclassification attracts investor attention
26/09/2025
Silver prices soar to record highs in India driven by strong global cues
26/09/2025
